Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Spahn

Showing results (81-90 of 106) with videos related to

Pageof 11
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 17, 2023
Perioperative Chemoimmunotherapy With Durvalumab for Muscle-Invasive Urothelial Carcinoma: Primary Analysis of the Single-Arm Phase II Trial SAKK 06/17Richard Cathomas, Sacha I Rothschild, Stefanie Hayoz, et al.
European Urology|April 2, 2014
Pretreatment tables predicting pathologic stage of locally advanced prostate cancerSteven Joniau, Martin Spahn, Alberto Briganti, et al.
BJU International|March 8, 2024
Safety and quality of cystectomy and pelvic lymph node dissection after neoadjuvant durvalumab and cisplatin/gemcitabineLuca Afferi, Martin Spahn, Stefanie Hayoz, et al.
Advances in Urology|March 9, 2012
The role of adjuvant hormonal treatment after surgery for localized high-risk prostate cancer: results of a matched multiinstitutional analysisMaria Schubert, Steven Joniau, Paolo Gontero, et al.
European Urology Oncology|July 7, 2019
Defining the Most Informative Intermediate Clinical Endpoints for Predicting Overall Survival in Patients Treated with Radical Prostatectomy for High-risk Prostate CancerAlberto Martini, Giorgio Gandaglia, R Jeffrey Karnes, et al.
European Urology Oncology|July 13, 2024
Effect of Radical Prostatectomy on Survival for Men with High-risk Nonmetastatic Prostate Cancer Features Selected According to STAMPEDE Criteria: An EMPaCT StudyDaimantas Milonas, Alexander Giesen, Annouschka Laenen, et al.
European Urology Open Science|August 18, 2025
Prognostic Stratification of pN1 Prostate Cancer After Radical Prostatectomy: A Competing Risk Analysis from a Multi-institutional CohortAlexander Giesen, Daimantas Milonas, Annouschka Laenen, et al.
European Urology Open Science|July 23, 2024
Risk of Cancer-related Death for Men with Biopsy Grade Group 1 Prostate Cancer and High-risk Features: A European Multi-institutional StudyDaimantas Milonas, Alexander Giesen, Tim Muilwijk, et al.
European Urology|December 9, 2008
Surgery for metastatic urothelial carcinoma with curative intent: the German experience (AUO AB 30/05)Jan Lehmann, Henrik Suttmann, Peter Albers, et al.
Frontiers in Oncology|March 27, 2020
Preoperative Risk-Stratification of High-Risk Prostate Cancer: A Multicenter AnalysisBrecht Chys, Gaëtan Devos, Wouter Everaerts, et al.
Pageof 11

Showing results (81-90 of 106) with videos related to

Sort By:
Pageof 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 17, 2023
Perioperative Chemoimmunotherapy With Durvalumab for Muscle-Invasive Urothelial Carcinoma: Primary Analysis of the Single-Arm Phase II Trial SAKK 06/17Richard Cathomas, Sacha I Rothschild, Stefanie Hayoz, et al.
European Urology|April 2, 2014
Pretreatment tables predicting pathologic stage of locally advanced prostate cancerSteven Joniau, Martin Spahn, Alberto Briganti, et al.
BJU International|March 8, 2024
Safety and quality of cystectomy and pelvic lymph node dissection after neoadjuvant durvalumab and cisplatin/gemcitabineLuca Afferi, Martin Spahn, Stefanie Hayoz, et al.
Advances in Urology|March 9, 2012
The role of adjuvant hormonal treatment after surgery for localized high-risk prostate cancer: results of a matched multiinstitutional analysisMaria Schubert, Steven Joniau, Paolo Gontero, et al.
European Urology Oncology|July 7, 2019
Defining the Most Informative Intermediate Clinical Endpoints for Predicting Overall Survival in Patients Treated with Radical Prostatectomy for High-risk Prostate CancerAlberto Martini, Giorgio Gandaglia, R Jeffrey Karnes, et al.
European Urology Oncology|July 13, 2024
Effect of Radical Prostatectomy on Survival for Men with High-risk Nonmetastatic Prostate Cancer Features Selected According to STAMPEDE Criteria: An EMPaCT StudyDaimantas Milonas, Alexander Giesen, Annouschka Laenen, et al.
European Urology Open Science|August 18, 2025
Prognostic Stratification of pN1 Prostate Cancer After Radical Prostatectomy: A Competing Risk Analysis from a Multi-institutional CohortAlexander Giesen, Daimantas Milonas, Annouschka Laenen, et al.
European Urology Open Science|July 23, 2024
Risk of Cancer-related Death for Men with Biopsy Grade Group 1 Prostate Cancer and High-risk Features: A European Multi-institutional StudyDaimantas Milonas, Alexander Giesen, Tim Muilwijk, et al.
European Urology|December 9, 2008
Surgery for metastatic urothelial carcinoma with curative intent: the German experience (AUO AB 30/05)Jan Lehmann, Henrik Suttmann, Peter Albers, et al.
Frontiers in Oncology|March 27, 2020
Preoperative Risk-Stratification of High-Risk Prostate Cancer: A Multicenter AnalysisBrecht Chys, Gaëtan Devos, Wouter Everaerts, et al.
Pageof 11